Michael Cloonan
2019
In 2019, Michael Cloonan earned a total compensation of $5M as Chief Business Officer at Sage Therapeutics, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,978 |
|---|---|
| Option Awards | $2,439,200 |
| Salary | $468,652 |
| Stock Awards | $1,930,968 |
| Other | $9,123 |
| Total | $4,952,921 |
Cloonan received $2.4M in option awards, accounting for 49% of the total pay in 2019.
Cloonan also received $105K in non-equity incentive plan, $468.7K in salary, $1.9M in stock awards and $9.1K in other compensation.
Rankings
In 2019, Michael Cloonan's compensation ranked 2,230th out of 13,971 executives tracked by ExecPay. In other words, Cloonan earned more than 84.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,230 out of 13,971 | 84th |
Division Manufacturing | 809 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 256 out of 2,200 | 88th |
Industry group Drugs | 207 out of 1,886 | 89th |
Industry Pharmaceutical Preparations | 151 out of 1,398 | 89th |
Pay ratio
| Michael Cloonan's Pay | $4,952,921 |
|---|---|
| Median Employee's Pay | $369,650 |
| Pay Ratio | 13to 1 |
In 2019, the annual total compensation of Michael Cloonan was $4,952,921.
The annual total compensation of the median employee at Sage Therapeutics was $369,650.
The ratio of Michael Cloonan's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on April 29, 2020.
Cloonan's colleagues
We found five more compensation records of executives who worked with Michael Cloonan at Sage Therapeutics in 2019.